Extensions for Using Data Elements from FHIR DSTU2 in FHIR R5
0.1.0 - STU International flag

Extensions for Using Data Elements from FHIR DSTU2 in FHIR R5 - Downloaded Version null See the Directory of published versions

ValueSet: R2V3SubstanceAdminSubstitutionForR5

Official URL: http://hl7.org/fhir/uv/xver/ValueSet/R2-v3-substanceAdminSubstitution-for-R5 Version: 0.1.0
Standards status: Trial-use Maturity Level: 0 Computable Name: R2V3SubstanceAdminSubstitutionForR5

This cross-version ValueSet represents content from http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2015-07-31 for use in FHIR R5.

This value set is part of the cross-version definitions generated to enable use of the value set http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2015-07-31 as defined in FHIR DSTU2 in FHIR R5.

The source value set is bound to the following FHIR DSTU2 elements:

Note that all concepts are included in this cross-version definition because no concepts have compatible representations

Following are the generation technical comments:

FHIR ValueSet http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2015-07-31, defined in FHIR DSTU2 does not have any mapping to FHIR R5

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

  • Include these codes as defined in http://hl7.org/fhir/v3/substanceAdminSubstitution version 📍1.0.2
    CodeDisplayDefinition
    BCbrand compositionDescription: Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven
    EequivalentDescription: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.
    ECequivalent compositionDescription: Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril
    FformularyDescription: This substitution was performed or is permitted based on formulary guidelines.
    Ggeneric compositionDescription: Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
    NnoneNo substitution occurred or is permitted.
    TBtherapeutic brandDescription: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics > Examples: Zantac for Tagamet
    TEtherapeutic alternativeDescription: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet
    TGtherapeutic genericDescription: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands > Examples: Ranitidine for cimetidine
    _ActSubstanceAdminSubstitutionCodeActSubstanceAdminSubstitutionCodeDescription: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.

 

Expansion

This value set expansion contains 10 concepts.

SystemVersionCodeDisplayDefinitionJSONXML
http://hl7.org/fhir/v3/substanceAdminSubstitution1.0.2  BCbrand compositionDescription: Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven
http://hl7.org/fhir/v3/substanceAdminSubstitution1.0.2  EequivalentDescription: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.
http://hl7.org/fhir/v3/substanceAdminSubstitution1.0.2  ECequivalent compositionDescription: Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril
http://hl7.org/fhir/v3/substanceAdminSubstitution1.0.2  FformularyDescription: This substitution was performed or is permitted based on formulary guidelines.
http://hl7.org/fhir/v3/substanceAdminSubstitution1.0.2  Ggeneric compositionDescription: Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
http://hl7.org/fhir/v3/substanceAdminSubstitution1.0.2  NnoneNo substitution occurred or is permitted.
http://hl7.org/fhir/v3/substanceAdminSubstitution1.0.2  TBtherapeutic brandDescription: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics > Examples: Zantac for Tagamet
http://hl7.org/fhir/v3/substanceAdminSubstitution1.0.2  TEtherapeutic alternativeDescription: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet
http://hl7.org/fhir/v3/substanceAdminSubstitution1.0.2  TGtherapeutic genericDescription: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands > Examples: Ranitidine for cimetidine
http://hl7.org/fhir/v3/substanceAdminSubstitution1.0.2  _ActSubstanceAdminSubstitutionCodeActSubstanceAdminSubstitutionCodeDescription: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code